The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

Laser causes elimination and miniaturization of hair shafts that are the principal contributor to inflammation in Acne Keloidalis Nuchae (AKN).

n/a

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00757315` - NdYag Laser for Acne Keloidalis Nuchae	N/A
Recruiting	`NCT05608499` - Duobrii Treatment of Acne Keloidalis Nuchae (AKN)	Phase 3
Completed	`NCT02372786` - 7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream	Phase 4
Terminated	`NCT00476697` - UVA1 Light for Scleroderma and Similar Conditions	N/A
Completed	`NCT01328080` - Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy	N/A